HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway
- PMID: 31524228
- PMCID: PMC6657962
- DOI: 10.3892/ijmm.2019.4276
HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway
Abstract
Pressure overload‑induced cardiac hypertrophy is associated with a complex spectrum of pathophysiological mechanisms, including the inflammation response. High mobility group box‑1 (HMGB1), a pro‑inflammatory cytokine, is not only increased in myocardium under pressure overload, but also exacerbates pressure overload‑induced cardiac hypertrophy and dysfunction; however, the underlying mechanisms have remained elusive. In the present study, cultured cardiomyocytes were stimulated by mechanical stress and/or HMGB1 for various durations to examine the role of HMGB1 in cardiomyocyte hypertrophy, and to detect the expression of receptor for advanced glycation end products (RAGE), toll‑like receptor 4 (TLR‑4) and the activation status of mitogen‑activated protein kinases (MAPKs) and Janus kinase 2 (JAK2)/STAT3. The results indicated that HMGB1 aggravated mechanical stress‑induced cardiomyocyte hypertrophy. Furthermore, mechanical stress and HMGB1 stimulation activated extracellular signal‑regulated kinase 1/2 (ERK1/2), P38 and JAK2/STAT3 signaling in cardiomyocytes, but an additive effect of the combined stimuli was only observed on the activation of ERK1/2. In addition, mechanical stress caused a prompt upregulation of the expression of RAGE and TLR‑4 in cardiomyocytes, while the activation of ERK1/2 by HMGB1 was inhibited by blockage of RAGE, but not by blockage of TLR‑4. In summary, the present results indicated that extracellular HMGB1 enhanced mechanical stress‑induced cardiomyocyte hypertrophy in vitro, at least partially via the RAGE/ERK1/2 signaling pathway.
Figures
Similar articles
-
sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.Inflamm Res. 2018 Aug;67(8):691-701. doi: 10.1007/s00011-018-1160-9. Epub 2018 May 23. Inflamm Res. 2018. PMID: 29796842
-
HMGB1-RAGE Axis Makes No Contribution to Cardiac Remodeling Induced by Pressure-Overload.PLoS One. 2016 Jun 29;11(6):e0158514. doi: 10.1371/journal.pone.0158514. eCollection 2016. PLoS One. 2016. PMID: 27355349 Free PMC article.
-
High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells.Am J Physiol Lung Cell Mol Physiol. 2015 Dec 1;309(11):L1354-66. doi: 10.1152/ajplung.00054.2015. Epub 2015 Oct 2. Am J Physiol Lung Cell Mol Physiol. 2015. PMID: 26432865
-
Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical results.Pharmacol Res. 2020 Jun;156:104792. doi: 10.1016/j.phrs.2020.104792. Epub 2020 Apr 8. Pharmacol Res. 2020. PMID: 32278047 Review.
-
HMGB1 signaling pathway in diabetes-related dementia: Blood-brain barrier breakdown, brain insulin resistance, and Aβ accumulation.Biomed Pharmacother. 2022 Jun;150:112933. doi: 10.1016/j.biopha.2022.112933. Epub 2022 Apr 9. Biomed Pharmacother. 2022. PMID: 35413600 Review.
Cited by
-
Differential Expression of Circulating Damage-Associated Molecular Patterns in Patients with Coronary Artery Ectasia.Biomolecules. 2023 Dec 21;14(1):10. doi: 10.3390/biom14010010. Biomolecules. 2023. PMID: 38275751 Free PMC article.
-
Toll-like receptors in cardiac hypertrophy.Front Cardiovasc Med. 2023 Apr 11;10:1143583. doi: 10.3389/fcvm.2023.1143583. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37113698 Free PMC article. Review.
-
Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa B signaling pathway.Front Mol Neurosci. 2022 Sep 16;15:1013033. doi: 10.3389/fnmol.2022.1013033. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36187352 Free PMC article. Review.
-
Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage.Ann Med Surg (Lond). 2022 Mar 21;76:103501. doi: 10.1016/j.amsu.2022.103501. eCollection 2022 Apr. Ann Med Surg (Lond). 2022. PMID: 35340325 Free PMC article. Review.
-
Paracrine signal emanating from stressed cardiomyocytes aggravates inflammatory microenvironment in diabetic cardiomyopathy.iScience. 2022 Feb 23;25(3):103973. doi: 10.1016/j.isci.2022.103973. eCollection 2022 Mar 18. iScience. 2022. PMID: 35281739 Free PMC article.
References
-
- Kwon HK, Jeong H, Hwang D, Park ZY. Comparative proteomic analysis of mouse models of pathological and physiological cardiac hypertrophy, with selection of biomarkers of pathological hypertrophy by integrative Proteogenomics. Biochim Biophys Acta Proteins Proteom 30118-30123. 2018 Jul 23; doi: 10.1016/j.bbapap.2018.07.006. Epub ahead of print. - DOI - PubMed
-
- Higashikuni Y, Tanaka K, Kato M, Nureki O, Hirata Y, Nagai R, Komuro I, Sata M. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1beta upregulation via nuclear factor kappaB activation. J Am Heart Assoc. 2013;2:e000267. doi: 10.1161/JAHA.113.000267. - DOI - PMC - PubMed
-
- Verma SK, Krishnamurthy P, Barefield D, Singh N, Gupta R, Lambers E, Thal M, Mackie A, Hoxha E, Ramirez V, et al. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB. Circulation. 2012;126:418–429. doi: 10.1161/CIRCULATIONAHA.112.112185. - DOI - PMC - PubMed
-
- Sun M, Chen M, Dawood F, Zurawska U, Li JY, Parker T, Kassiri Z, Kirshenbaum LA, Arnold M, Khokha R, Liu PP. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation. 2007;115:1398–1407. doi: 10.1161/CIRCULATIONAHA.106.643585. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
